Gene mutations passed from parent to child can drastically raise the risk of disease, including many types of cancer. In fact, patients with certain rare hereditary cancer syndromes may have an up to 100 percent chance of getting certain types of cancer.
The ongoing discovery of genes involved in cancer allows us to test for cancer-causing mutations in these genes, which may increase cancer risk. If your patient has a mutation that puts him/her at an increased risk of cancer, you can take action to help reduce the risk of cancer through increased surveillance, chemoprevention, prophylactic surgery and counseling about risk. Identifying the potential risk of cancer is the first step in determining the best way to possibly delay, or even prevent, the development of certain cancers.*
The Myriad MyRisk hereditary cancer test provides vital information to help you and your patients with a personal or family history of cancer understand the risk of developing disease. Armed with the results of genetic testing, you can take steps to potentially prevent the disease, delay its onset, or catch it at an earlier stage when outcomes are likely to be better. This information can help improve health and quality of life while reducing healthcare costs.
Myriad’s hereditary cancer testing products have been used to help millions of patients with a personal or family history of cancer. These patients usually develop cancer at a young age or have cancer in their families that occur at a young age (e.g., below 50). Patients may also have cancer that occurs in several family members or multiple times in the same individual. The cancers can be found in the patient and/or on either the maternal or paternal side of the family.
Myriad MyRisk™ Hereditary Cancer panel is a multigene panel test that can help to determine your patient’s cancer risk with a focus on eight important cancers:
Learn more about Myriad MyRisk™ Hereditary Cancer.
*Any discussion of medical management options is for general informational purposes only and does not constitute a recommendation. While genetic testing and medical society guidelines provide important and useful information, all medical management decisions should be made based on consultation between each patient and his or her healthcare professional.